证券日报网讯 12月12日，精工科技在互动平台回答投资者提问时表示，截至目前，公司暂无产品应用 到半导体上。 （文章来源：证券日报） ...

格隆汇12月12日丨精工科技(002006.SZ)在投资者互动平台表示，截至目前，公司暂无产品应用到半导 体上。 ...

格隆汇12月12日丨精工科技(002006.SZ)在投资者互动平台表示，公司迭代和优化升级的第二代单关节 外骨骼机器人已具备量产能力，公司全资子公司浙江显力智能科技有限公司作为外骨骼机器人业务的运 营平台，正在开展产业化、商业模式策划等工作。 ...

格隆汇12月12日丨精工科技(002006.SZ)在投资者互动平台表示，公司迭代和优化升级的第二代单关节 外骨骼机器人已具备量产能力，公司全资子公司浙江显力智能科技有限公司作为外骨骼机器人业务的运 营平台，正在开展产业化、商业模式策划等工作。 ...

Core Viewpoint - Jinggong Technology has signed a sales contract worth 729 million yuan with Hubei Yuchuang for the provision of carbon fiber production lines, marking a significant step in expanding its carbon fiber equipment market share and enhancing future operational performance [1][2]. Group 1: Sales Contract and Financial Impact - The contract includes two 5000-ton high-performance PAN-based carbon fiber precursor production lines and one 3000-ton carbon fiber production line [2]. - The contract amount represents 42.16% of the company's audited revenue for the fiscal year 2024 [2]. - The successful implementation of this contract is expected to positively impact the company's operational performance by expanding production and sales scale [2]. Group 2: Business Performance and Growth - In the first three quarters of 2025, Jinggong Technology achieved a revenue of 1.343 billion yuan, a year-on-year increase of 13.70%, and a net profit attributable to shareholders of 145 million yuan, up 98.18% [6][8]. - The carbon fiber equipment business is the main driver of revenue growth, with sales revenue reaching 629 million yuan in the first half of 2025, a 59.53% increase year-on-year, accounting for nearly 60% of total revenue [3][6]. - The company's gross margin improved to 29.78%, an increase of 5.41 percentage points year-on-year, while the net profit margin rose to 10.78%, up 4.59 percentage points [6]. Group 3: Research and Development - Jinggong Technology has invested significantly in R&D, with R&D expenses exceeding 100 million yuan annually from 2022 to 2024, and a R&D expense rate of 6.51% in the first three quarters of 2025 [7]. - The company has established a strong brand recognition and has received accolades for its innovative products, including the first domestic 1000-ton carbon fiber production line [7]. Group 4: Market Strategy and Future Outlook - The company is focused on expanding its market presence both domestically and internationally, with a strategy to enhance its order fulfillment and attract new customers [4]. - Jinggong Technology is actively pursuing the construction of intelligent manufacturing projects in carbon fiber and composite materials to meet market demands [8].

Group 1 - The core point of the article is that Jinggong Technology (002006) has signed a sales contract with Hubei Yuchuang Carbon Fiber Co., Ltd. for the provision of two 5000-ton high-performance PAN-based carbon fiber precursor production lines and one 3000-ton carbon fiber production line, with a total contract value of 729 million yuan [1] Group 2 - The contract includes the delivery of advanced production lines, indicating a strategic move to enhance production capacity in the carbon fiber sector [1] - The total contract amount of 729 million yuan reflects significant investment in carbon fiber technology, which is crucial for various high-performance applications [1]

Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]

Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

每经头条（nbdtoutiao）——处方药变"瘾品"：国内首次报告普瑞巴林滥用致成瘾病例，网络平台暴 露"无病历可购药"漏洞，列管与否尚需科学考量 （记者 曾健辉） 每经AI快讯，精工科技（SZ 002006，收盘价：22.39元）12月9日晚间发布公告称，公司第九届第十三 次董事会会议于2025年12月6日以通讯表决方式召开。会议审议了《关于与湖北裕创碳纤维有限公司签 署销售合同暨关联交易的议案》等文件。 2024年1至12月份，精工科技的营业收入构成为：专用设备制造业占比99.4%，其他业务占比0.6%。 截至发稿，精工科技市值为116亿元。 ...

证券代码：002006 证券简称：精工科技 公告编号：2025-054 浙江精工集成科技股份有限公司关于与湖北裕创碳纤维有限公司 签署销售合同暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江精工集成科技股份有限公司 一、关联交易概述 浙江精工集成科技股份有限公司（以下简称精工科技或公司）于 2025 年 12 月 4 日在《证券时报》及巨潮资讯网（http://www.cninfo.com.cn）披露了《关 于中标武汉青山高性能碳纤维生产基地项目的提示性公告》（公告编号： 2025-051），公司中标湖北裕创碳纤维有限公司（以下简称湖北裕创）公开招标 的《武汉青山高性能碳纤维生产基地项目》，中标金额为 7.29 亿元。 因公司副总裁倪建勋先生在湖北裕创担任董事，根据《深圳证券交易所股票 上市规则》第 6.3.3 条第（四）款之规定，本次公司参与上述公开招标中标事项 构成关联交易，公司与湖北裕创签署销售合同需履行关联交易的决策审批程序。 上述关联交易事项经公司独立董事专门会议事前审议通过后，已提请 2025 年 12 月 6 日公司召开的第 ...